Shanghai Titan Scientific Co., Ltd. (SHA:688133)
China · Delayed Price · Currency is CNY 21.04
-0.46 (-2.14%)
Jul 3, 2026, 3:00 PM CST
Shanghai Titan Scientific Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,500 | 2,521 | 2,883 | 2,769 | 2,607 | 2,164 |
Other Revenue | 0.54 | 0.54 | 0.65 | 0.56 | 0.95 | 0.3 |
| 2,500 | 2,521 | 2,884 | 2,770 | 2,608 | 2,164 | |
Revenue Growth (YoY) | -11.44% | -12.56% | 4.11% | 6.20% | 20.50% | 56.32% |
Cost of Revenue | 2,032 | 2,023 | 2,317 | 2,193 | 2,044 | 1,706 |
Gross Profit | 468.81 | 498.37 | 566.07 | 576.24 | 563.42 | 457.8 |
Selling, General & Admin | 397.16 | 384.48 | 382.82 | 341.18 | 271.78 | 202.93 |
Research & Development | 143.51 | 142.01 | 133.99 | 136.16 | 114.17 | 81.81 |
Other Operating Expenses | -1.87 | 6.54 | 7.13 | 5.54 | 6.62 | 5.69 |
Operating Expenses | 545.13 | 538.14 | 531.91 | 494.3 | 408.79 | 301.47 |
Operating Income | -76.32 | -39.77 | 34.16 | 81.94 | 154.64 | 156.33 |
Interest Expense | -46.12 | -45.11 | -40.82 | -27.99 | -27 | -9.79 |
Interest & Investment Income | 6.2 | 7.21 | 10.61 | 13.98 | 10.43 | 8.83 |
Currency Exchange Gain (Loss) | -1.69 | -1.69 | -0.8 | -3.63 | -2.86 | 0.13 |
Other Non Operating Income (Expenses) | -1.85 | -2.67 | -3.37 | -3.7 | -2.7 | -3.26 |
EBT Excluding Unusual Items | -119.79 | -82.03 | -0.21 | 60.61 | 132.51 | 152.25 |
Impairment of Goodwill | -29.55 | -29.55 | - | - | - | - |
Gain (Loss) on Sale of Investments | 19.73 | 19.7 | 1.77 | 11.33 | - | 12.22 |
Gain (Loss) on Sale of Assets | -0.07 | -0.07 | 1.88 | 0.62 | - | -0.01 |
Asset Writedown | -1.49 | -1.14 | -0.15 | - | - | - |
Other Unusual Items | 51.2 | 51.52 | 3.64 | 12.63 | 18.59 | 5.25 |
Pretax Income | -79.96 | -41.58 | 6.93 | 85.19 | 151.09 | 169.72 |
Income Tax Expense | 1.23 | 1.79 | -0.83 | 9.88 | 19.38 | 27.43 |
Earnings From Continuing Operations | -81.19 | -43.37 | 7.76 | 75.31 | 131.72 | 142.29 |
Minority Interest in Earnings | 12.76 | 12.45 | 5.13 | -2.74 | -6.91 | 1.67 |
Net Income | -68.44 | -30.92 | 12.89 | 72.57 | 124.81 | 143.95 |
Net Income to Common | -68.44 | -30.92 | 12.89 | 72.57 | 124.81 | 143.95 |
Net Income Growth | - | - | -82.23% | -41.85% | -13.30% | 40.09% |
Shares Outstanding (Basic) | 160 | 163 | 161 | 164 | 155 | 149 |
Shares Outstanding (Diluted) | 160 | 163 | 161 | 164 | 155 | 149 |
Shares Change (YoY) | -1.89% | 0.98% | -1.64% | 5.83% | 3.72% | 26.00% |
EPS (Basic) | -0.43 | -0.19 | 0.08 | 0.44 | 0.81 | 0.96 |
EPS (Diluted) | -0.43 | -0.19 | 0.08 | 0.44 | 0.81 | 0.96 |
EPS Growth | - | - | -81.94% | -45.06% | -16.41% | 11.18% |
Free Cash Flow | -20.24 | -47.27 | -291.93 | -589.46 | -450.97 | -377.43 |
Free Cash Flow Per Share | -0.13 | -0.29 | -1.81 | -3.60 | -2.91 | -2.53 |
Dividend Per Share | - | - | 0.070 | 0.071 | 0.102 | 0.102 |
Dividend Growth | - | - | -1.96% | -30.00% | 0.20% | -51.34% |
Gross Margin | 18.75% | 19.77% | 19.63% | 20.81% | 21.61% | 21.15% |
Operating Margin | -3.05% | -1.58% | 1.19% | 2.96% | 5.93% | 7.22% |
Profit Margin | -2.74% | -1.23% | 0.45% | 2.62% | 4.79% | 6.65% |
Free Cash Flow Margin | -0.81% | -1.88% | -10.12% | -21.28% | -17.29% | -17.44% |
EBITDA | -4.51 | 31.1 | 101.27 | 122.27 | 181.94 | 172.22 |
EBITDA Margin | -0.18% | 1.23% | 3.51% | 4.41% | 6.98% | 7.96% |
D&A For EBITDA | 71.81 | 70.87 | 67.1 | 40.32 | 27.3 | 15.88 |
EBIT | -76.32 | -39.77 | 34.16 | 81.94 | 154.64 | 156.33 |
EBIT Margin | -3.05% | -1.58% | 1.19% | 2.96% | 5.93% | 7.22% |
Effective Tax Rate | - | - | - | 11.60% | 12.82% | 16.16% |
Revenue as Reported | - | - | - | 2,770 | 2,608 | 2,164 |
Advertising Expenses | - | 10.76 | 16.21 | 15.15 | 9.35 | 12.1 |